OCT in STEMI Patients: Is It Safe to Prevent Stenting?

Percutaneous coronary intervention in patients with acute myocardial infarction (AMI) where the physiopathological mechanism is plaque erosion or non-atherosclerotic mechanisms (such as spontaneous coronary artery dissection) is not beneficial according to recent studies. 

OCT en pacientes con SCACEST, ¿Es seguro utilizarlo para evitar implante de stent?

The EROSION study (Effective Anti-Thrombotic Therapy Without Stenting: Intravascular Optical Coherence Tomography–Based Management in Plaque Erosion) has shown medical treatment with no stenting might be an option to treat plaque erosion driven AMI. To assess the etiological differences generated by a coronary event using optical coherence tomography (OCT) is ideal.

The aim of this multicenter, prospective, randomized study in STEMI patients followed up at one year, was to examine whether OCT guided revascularization is associated with lower stenting rate vs. conventional angiography guided revascularization. 

Primary effectiveness end point was stent implantation rate in both groups. Safety end point was incidence of the composite of cardiovascular death, repeat MI, target vessel revascularization and unstable angina. Secondary end point included the incidence of cerebro and cardiovascular events at 1 year. 

226 patients were included, 112 in the OCT group and 114 in the angiography group. Mean age was 55, mostly were men. Culprit lesion was most frequently located in the anterior descending (49%) and right coronary arteries (40%).

Read also: RESTORE | Using Rivaroxaban to Prevent Radial Artery Occlusion After an Intervention.

Total stent implantation rate was 51%, OCT presenting the lowest rate compared against the angiography group (43.8% vs 58.8%; P = 0.024). there were no significant differences in secondary end point. 

Conclusion

In STEMI patients with early infarct artery patency with no significative stenosis compared against the angiography guided group, OCT reduced stent implantation rate.  Further study is required to determine the clinical benefits of OCT guided reperfusion.

Dr. Andrés Rodríguez
Member of the Editorial Board in SOLACI.org .

Original Title: EROSION III A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency.

Reference: Haibo Jia, MD, PHD et al. J Am Coll Cardiol Intv 2022.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....